Pharma Collaboration Target large and mid-sized pharmaceutical and biotech companies seeking GPCR and kinase screening capabilities. Position Multispan as a trusted partner for assay development, HTS readiness, and SAR lead optimization to accelerate IND timelines.

Specialized GPCR Tech Leverage the company’s strength in endogenously expressed targets in primary cells and recombinant stable lines to win deals with teams prioritizing physiologically relevant screening. Emphasize high-quality GPCR-expressing resources as a differentiator.

Expandability Promise Highlight the ability to scale from assay development to high-throughput screening and lead optimization, offering a streamlined path from discovery to candidate nomination which appeals to sponsors aiming to shorten development cycles.

Quality and Longevity Promote established partnerships with global pharma and biotech players by showcasing a track record of reliability, rigorous quality standards, and repeat collaborations to reduce perceived risk for new customers.

Targeted Therapeutic Areas Align messaging around cardiovascular, metabolic, CNS, inflammation, immunology, and oncology indications where Multispan has demonstrated relevance. Propose joint exploration in niche subdomains to unlock new funding opportunities.